Sonova Holding AG stock (CH0012549785): shares steady after recent full-year results and updated guidance
05.06.2026 - 07:10:07 | ad-hoc-news.deSonova Holding AG shares are trading in relatively calm fashion on the SIX Swiss Exchange at the end of the week, as investors continue to digest the Swiss hearing-care company’s latest full-year results and guidance update released in May 2025.
According to SIX Swiss Exchange data, the stock last changed hands at around CHF 290 on 06/04/2025 in Zurich, reflecting a moderate move compared with levels seen immediately after the earnings release.SIX Swiss Exchange as of 06/04/2025
Sonova, headquartered in Stäfa in Switzerland, is a key constituent of the domestic equity market and a well-followed name for investors seeking exposure to the global hearing-aid and cochlear-implant segment.
In its full-year 2024/25 results published on 05/21/2025, the group reported sales of CHF 4.07 billion and an adjusted EBITA of CHF 942 million for the twelve months ended 03/31/2025, underscoring its scale in the hearing-care market.Sonova investor release as of 05/21/2025
The company also communicated an earnings per share figure (basic) of CHF 10.87 for FY 2024/25, according to the same results release dated 05/21/2025, which is an important reference point for investors tracking the stock’s profitability over time.Sonova annual report as of 05/21/2025
From a Swiss domestic perspective, Sonova’s listing on SIX underpins its relevance to regional equity indices and to local institutional investors that benchmark against the Swiss Performance Index and other home-market barometers.
As of: 05/06/2026
By the editorial team - specialized in equity coverage.
At a glance
- Name: Sonova
- Sector/industry: Hearing-care medical technology and services
- Headquarters/country: Stäfa, Switzerland
- Core markets: Europe, North America, Asia-Pacific
- Key revenue drivers: Hearing instruments, cochlear implants, audiological services
- Home exchange/listing venue: SIX Swiss Exchange (SONN)
- Trading currency: CHF
Sonova Holding AG: core business model
Sonova develops and manufactures hearing instruments and cochlear implants while also operating retail audiological networks, with sales largely driven by demand for technologically advanced hearing solutions sold through clinics, retailers, and professional channels worldwide.
Valuation metrics and multiples for Sonova Holding AG
Based on the FY 2024/25 basic earnings per share of CHF 10.87 disclosed in the company’s annual report dated 05/21/2025, Sonova’s price-to-earnings ratio at a share price level of around CHF 290 on 06/04/2025 would be in the mid-20s, providing a reference point for how the market is valuing the Swiss hearing-care specialist relative to its recent earnings performance.Sonova annual report as of 05/21/2025
In its results communication on 05/21/2025, the company also referred to an adjusted EBITA margin of roughly the low-20 percent range for FY 2024/25, a profitability indicator that investors may combine with the share price to gauge enterprise-value-based ratios such as EV/EBITA when comparing Sonova with other medical-technology and hearing-care peers.Sonova investor release as of 05/21/2025
Read more
Additional news and developments on the stock can be explored via the linked overview pages.
Sentiment and reactions on Sonova Holding AG
Following the publication of the latest full-year figures and the subsequent consolidation in the share price, market participants are actively discussing Sonova Holding AG on financial social-media channels and video platforms.
Conclusion
Sonova Holding AG’s share price on the SIX Swiss Exchange is moving in a comparatively narrow band as investors weigh the FY 2024/25 results, which featured CHF 4.07 billion in sales and CHF 10.87 in basic EPS for the year ended 03/31/2025.
With these figures shaping valuation metrics such as the implied price-to-earnings ratio in the mid-20s area at a share price of roughly CHF 290, market participants continue to monitor how the Swiss hearing-care company balances growth, margins, and investment in technology while trading as an established name in the domestic equity market.
Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.
So schätzen die Börsenprofis Sonova Aktien ein!
Für. Immer. Kostenlos.
